Network of Interactions Between Gut Microbiome, Host Biomarkers, and Urine Metabolome in Carotid Atherosclerosis

Ruijun Li, Zhuye Jie, Qiang Feng, Ruiling Fang, Fei Li, Yuan Gao, Huihua Xia, Huanzi Zhong, Bin Tong, Lise Madsen, Jiahao Zhang, Chunlei Liu, Zhenguo Xu, Jian Wang, Huanming Yang, Xun Xu, Yong Hou, Susanne Brix, Karsten Kristiansen, Xinlei Yu, Huijue Jia, Kunlun HeFrontiers in Cellular and Infection Microbiology 2021 · DOI

TL;DR

This study integrates gut microbiome, blood biomarkers, and urine metabolomics data from individuals with varying metabolic conditions to map complex interactions. They reveal a tight-knit network between gut microbes and urine metabolites, suggesting the urine metabolome may reflect gut microbiome composition and hold potential as a biomarker for diseases like carotid atherosclerosis.

What Problem Does This Paper Address?

Understanding complex diseases like carotid atherosclerosis requires looking beyond single biological layers. These diseases are influenced by a multitude of factors, including the trillions of microbes in our gut, our systemic physiological state (reflected in blood biomarkers), and the chemical byproducts of metabolism excreted in urine. However, the intricate interplay between these systems and how they collectively contribute to disease development remains largely uncharacterized. This paper aims to bridge this gap by using a multi-omics approach to map these interactions and identify potential biomarkers for diseases, specifically focusing on carotid atherosclerosis.

Methods

The researchers employed a comprehensive "trans-omics" approach, integrating three distinct data types:

  • Gut Microbiome Profiling: Shotgun metagenomic sequencing was used to identify microbial species (Metagenomic Species, MGS) and their functional potential in fecal samples.
  • Blood Biomarker Analysis: A panel of 124 clinical blood parameters was collected for each participant.
  • Urine Metabolomics: High-resolution mass spectrometry (UPLC-QTOF) was used to profile a vast number of metabolites in urine samples.

To analyze the relationships between these datasets, they utilized:

  • Spearman Correlation: To identify pairwise associations between microbial features, metabolites, and clinical parameters.
  • Network Modeling (Girvan-Newman algorithm): To visualize and understand the community structure of these inter-domain correlations, revealing clusters of interacting entities.
  • Random Forest Models: To predict clinical parameters from microbiome data and to classify individuals with and without carotid atherosclerosis.

Datasets

The study utilized data from 138 treatment-naïve individuals recruited during a carotid atherosclerosis screening program. This cohort presented a wide range of metabolic disease phenotypes. The data collected included:

  • Fecal samples for metagenomic sequencing.
  • Blood samples for analysis of 124 clinical parameters.
  • Urine samples for metabolomic profiling.

The study did not introduce a new benchmark dataset but rather analyzed existing data types in a novel integrated manner.

Key Insights and Ideas

  • Gut-Urine Metabolome Axis: The most striking finding is the strong, close-knit correlation network between gut microbial composition and urine metabolites. This suggests a direct or indirect communication pathway where gut microbial activity significantly influences the chemical profile of urine.
  • Urine Metabolome as a Mirror: The urine metabolome appears to be a sensitive indicator of both gut microbiome status and systemic physiological changes, potentially reflecting health or disease states more readily than the gut microbiome alone in certain contexts.
  • Liver Function Insights: Specific gut bacteria were linked to liver health. Eubacterium eligens, Faecalibacterium prausnitzii, and Ruminococcus lactaris were associated with healthy liver function, while others like Clostridium bolteae and Ruminococcus gnavus were linked to biomarkers of liver disease.
  • Carotid Atherosclerosis Biomarker Potential: While the gut microbiome showed only minor alterations in individuals with carotid atherosclerosis, urine metabolites, particularly a group structurally similar to 20,26-dihydroxyecdysone (ME71), showed significant promise as potential biomarkers, achieving a high classification accuracy.
  • Holistic Network View: The network modeling revealed two major communities: a dominant microbe-metabolite cluster and a smaller, but significant, microbe-metabolite-phenotype cluster, underscoring the interconnectedness of these biological systems.

Key Results

  • Microbiome-Metabolome Network: A large community of 200 MGS and 33 metabolite groups was identified, with 99.1% of connections being between microbes and metabolites.
  • Microbe-Metabolite-Phenotype Network: A second community linked 41 MGS, 53 metabolite groups, and 23 blood biomarkers.
  • Liver Function Associations: Identified specific bacteria associated with healthy vs. diseased liver function markers.
  • Carotid Atherosclerosis Classification:
    • Blood biomarkers achieved an AUC of 0.87 for classifying carotid atherosclerosis.
  • Gut microbiome composition (MGS) achieved a lower AUC of 0.54.
  • Urine metabolome achieved an AUC of 0.72.
  • A single urine metabolite group (ME71) achieved an AUC of 0.78, demonstrating its potential as a specific biomarker.

Limitations and Future Work

  • Causality vs. Correlation: The study primarily identifies correlations, and while suggestive, it does not definitively establish causal relationships between the gut microbiome, urine metabolome, and carotid atherosclerosis. Further mechanistic studies are needed.
  • Sample Size for Control Group: The authors note that due to the small sample size of the control group, robust comparisons of trans-omics networks between cases and controls were limited.
  • Biomarker Validation: While ME71 showed promising results, the authors emphasize the need for further validation of its use as a biomarker for carotid atherosclerosis, noting variations within groups.
  • Future Directions: The study suggests that future research should focus on identifying specific mechanisms underlying these observed interactions and on validating potential biomarkers in larger, diverse cohorts. The authors also highlight the potential for using these multi-omics networks to identify therapeutic targets.

Summary updated

Abstract

Comprehensive analyses of multi-omics data may provide insights into interactions between different biological layers concerning distinct clinical features. We integrated data on the gut microbiota, blood parameters and urine metabolites of treatment-naive individuals presenting a wide range of metabolic disease phenotypes to delineate clinically meaningful associations. Trans-omics correlation networks revealed that candidate gut microbial biomarkers and urine metabolite feature were covaried with distinct clinical phenotypes. Integration of the gut microbiome, the urine metabolome and the phenome revealed that variations in one of these three systems correlated with changes in the other two. In a specific note about clinical parameters of liver function, we identified Eubacteriumeligens, Faecalibacteriumprausnitzii and Ruminococcuslactaris to be associated with a healthy liver function, whereas Clostridium bolteae, Tyzzerellanexills, Ruminococcusgnavus, Blautiahansenii, and Atopobiumparvulum were associated with blood biomarkers for liver diseases. Variations in these microbiota features paralleled changes in specific urine metabolites. Network modeling yielded two core clusters including one large gut microbe-urine metabolite close-knit cluster and one triangular cluster composed of a gut microbe-blood-urine network, demonstrating close inter-system crosstalk especially between the gut microbiome and the urine metabolome. Distinct clinical phenotypes are manifested in both the gut microbiome and the urine metabolome, and inter-domain connectivity takes the form of high-dimensional networks. Such networks may further our understanding of complex biological systems, and may provide a basis for identifying biomarkers for diseases. Deciphering the complexity of human physiology and disease requires a holistic and trans-omics approach integrating multi-layer data sets, including the gut microbiome and profiles of biological fluids. By studying the gut microbiome on carotid atherosclerosis, we identified microbial features associated with clinical parameters, and we observed that groups of urine metabolites correlated with groups of clinical parameters. Combining the three data sets, we revealed correlations of entities across the three systems, suggesting that physiological changes are reflected in each of the omics. Our findings provided insights into the interactive network between the gut microbiome, blood clinical parameters and the urine metabolome concerning physiological variations, and showed the promise of trans-omics study for biomarker discovery.
BibTeX
@inproceedings{li2021network,
  author = {Ruijun Li and Zhuye Jie and Qiang Feng and Ruiling Fang and Fei Li and Yuan Gao and Huihua Xia and Huanzi Zhong and Bin Tong and Lise Madsen and Jiahao Zhang and Chunlei Liu and Zhenguo Xu and Jian Wang and Huanming Yang and Xun Xu and Yong Hou and Susanne Brix and Karsten Kristiansen and Xinlei Yu and Huijue Jia and Kunlun He},
  title = {{Network of Interactions Between Gut Microbiome, Host Biomarkers, and Urine Metabolome in Carotid Atherosclerosis}},
  booktitle = {Frontiers in Cellular and Infection Microbiology},
  year = {2021},
  doi = {10.3389/fcimb.2021.708088},
}
Figure